BEFORE THE 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF THE SECRETARY 

WASHINGTON, D.C. 

•\RTMENT OF 

MSi^CRTATION 

" i OFERATIOMS 

o n 

Motion of 

US AIRWAYS, INC. 

for confidential treatment of documents pursuaat 

to Rule 12 of the Rules of Practice 

(Schedule B-7 of Form 41) 

Docket OST-96-1826 

(former Docket 48735) 

MOTION OF US AIRWAYS, INC. 

FOR CONFIDENTIAL TREATMENT 

Communications with respect to this document should be sent to: 

Howard Kass 

Vice President - Legal and Government Affairs 

Benjamin T. Slocum 

Director and Assistant General Counsel 

US Airways, Inc. 

1401 H Street, NW, Suite 1075 

Washington, DC 20005 

(202)326-5153 

howard.kass@usairways.com 

benjamin.slocum@usairways.com 

November 9,2011 
BEFORE THE 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF THE SECRETARY 

WASHINGTON, D.C. 

Motion of 

US AIRWAYS, INC. 

for confidential treatment of documents pursuant 

to Rule 12 of the Rules of Practice 

(Schedule B-7 of Form 41) 

Docket OST-96-1826 

(former Docket 48735) 

November 9,2011 

MOTION OF US AIRWAYS, INC. 

FOR CONFIDENTL\L TREATMENT 

Pursuant to Rule 12 of the Department's Rules of Practice (14 C.F.R. § 302.12), 

US Airways, Inc. ("US Airways") hereby requests confidential treatment of certain information 

contained in Schedule B-7 - Airframe and Aircraft Engine Acquisitions and Retirements of 

US Airways' Form 41 filing for the quarter ended September 30, 2011 ("Schedule B-7"). That 

filing will be submitted separately herewith under seal, marked with a request for confidential 

treatment pursuant to Rule 12 (§ 302.12). US Airways requests that these data be withheld fi-om 

public disclosure for a period of at least ten (10) years fi-om the date of their submission. In 

support of this request, US Airways states as follows: 

The Freedom of Information Act, 5 U.S.C. § 552(b)(4), provides that confidential 

commercial and financial information obtained from a private person is exempt from the 

requirements of public disclosure. The information for which US Airways requests confidential 

treatment is confidential and proprietary commercial and financial information obtained from 

US Airways, a private party. Moreover, the public release of that information would cause US 

1 
Motion of US Airways, Inc. for Confidential Treatment 

Airways substantial competitive and financial injury. Accordingly, the information should be 

withheld from public disclosure. 

The information at issue is cost, amortization/depreciation and realization data relating to 

US Airways' airframes and aircraft engines as of September 30, 2011. This information is 

presented in columns 10, 11, and 12 of Schedule B-7. See Exhibit A hereto for a listing of the 

specific information included in Schedule B-7 for which confidential treatment is requested. In 

addition to filing Schedule B-7 under seal, US Airways is submitting to the Office of Aviation 

Analysis redacted copies of Schedule B-7, available for public inspection, that omit the 

information for which confidential treatment is requested. 

The Department has previously determined that the confidential and competitivelysensitive data contained in US Airways' Schedules B-7 are entitled to confidential treatment. By 

letter of James W. Mitchell, Director, Office of Airline Statistics, the Department granted prior 

US Airways' requests for confidential treatment of this same information for earlier reporting 

periods and ruled that it be withheld from public disclosure for a period often (10) years. The 

Department's reasoning applies v^th equal force to US Airways' present motion and submission. 
Motion of US Ainvavs. Inc. for Confidential Treatment 

WHEREFORE, US Airways respectfiilly requests that the confidential information 

contained in its Schedule B-7 detailed above be withheld from public disclosure for at least ten 

(10) years. 

Respectfully submitted, 

&^i^r.M— 

HowdKass 

Vice President - Legal and Government Affairs 

Benjamin T. Slocum 

Director £ind Assistant General Counsel 

US Airways, Inc. 

1401 H Stireet, NW, Suite 1075 

Washington, DC 20005 

(202)326-5153 

howard.kass@usairways.com 

benj amin. slocum@usairways.com 

November 9,2011 
EXHIBIT A 

Listmg of Confidential Information in US Airways, Inc.'s Form 41 Filing 

Schedule B-7: 

Cost 

Title/Description Location in Docmnent Number of Pages 

Column (10) 

Depreciated Cost or 

Amortized Value 

Column (11) 

Realization Column (12)